To save women and children’s lives by improving the quality, availability and accessibility of (reproductive, maternal, new born and child health (RMNCH) services. Phase 1 of this programme will focus on increasing access to preventive services (including family planning, water, sanitation and long lasting insecticide treated bednets) and improving service quality in line with the maternal and child health priorities of the President’s 10-24 Month Recovery Plan. The second phase will embed and build on the gains of the first phase and will increase equitable access to the improved RMNH services, whilst strengthening priority health systems for more sustainable service delivery.
To improve the diet intake and nutritional practices in target beneficiaries (Infant and Young Child Feeding practices, hygiene, breastfeeding, water and sanitation) in the Beira corridor in Mozambique and promote the local production of Ready to Use Therapeutic Foods. This will target 623,000 beneficiaries and contribute to delivering MDG 1.C on reducing hunger. Key stakeholders (GoM, private sector and donors) influenced through credible, evidenced based models for effective nutrition interventions.
To accelerate access to essential commodities, improve health outcomes and achieve greater value for money for priority health areas including HIV, TB, malaria, family planning, and vaccines. This is achieved by making health commodity markets work better to bring more low-cost, high-quality manufacturers into markets and deliver greater competition, lower prices, faster rollout of new medicines, increased supply security, clearer demand visibility and enhanced incentives for innovation.
To significantly reduce stunting in young children by supporting the production, distribution and up take of quality complementary foods. The improvements are projected to save more than 225,000 lives over 4 years. These results would significantly contribute to DFID's global nutrition target to reach 20 million pregnant women and children under 5 through nutrition programmes.
The Credit Facility for Access to Medicines is an innovative social finance company committed to expanding and accelerating access to life-saving medicines, vaccines and diagnostics in Africa and South Asia. The company launched in 2017, with support and input from DFID, the Clinton Health Access Initiative and the Bill and Melinda Gates Foundation. The facility has been established as a wholly-owned subsidiary of CDC with an initial capital commitment of $200m.